Skip to main content
Top
Published in: Molecular Cancer 1/2013

Open Access 01-12-2013 | Research

Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma

Authors: Wen Zhou, Xiangling Feng, Caiping Ren, Xingjun Jiang, Weidong Liu, Wei Huang, Zhihong Liu, Zan Li, Liang Zeng, Lei Wang, Bin Zhu, Jia Shi, Jie Liu, Chang Zhang, Yanyu Liu, Kaitai Yao

Published in: Molecular Cancer | Issue 1/2013

Login to get access

Abstract

Background

Nasopharyngeal carcinoma (NPC) is a common malignant tumor in southern China and Southeast Asia, but its molecular mechanisms of pathogenesis are poorly understood. Our previous work has demonstrated that BCAT1 mRNA is over expressed in NPC and knocking down its expression in 5-8F NPC cell line can potently inhibit cell cycle progression and cell proliferation. However, the mechanism of BCAT1 up-regulation and its functional role in NPC development remain to be elucidated yet.

Methods

Immunohistochemistry (IHC) method was utilized to detect the expression of BCAT1 protein in NPC at different pathological stages. The roles of gene mutation, DNA amplification and transcription factor c-Myc in regulating BCAT1 expression were analyzed using PCR-sequencing, quantitative polymerase chain reaction (qPCR), IHC, ChIP and luciferase reporter system, respectively. The functions of BCAT1 in colony formation, cell migration and invasion properties were evaluated by RNA interference (RNAi).

Results

The positive rates of BCAT1 protein expression in normal epithelia, low-to-moderate grade atypical hyperplasia tissues, high-grade atypical hyperplasia tissues and NPC tissues were 23.6% (17/72), 75% (18/24 ), 88.9% (8/9) and 88.8% (71/80), respectively. Only one SNP site in exon1 was detected, and 42.4% (12/28) of the NPC tissues displayed the amplification of microsatellite loci in BCAT1. C-Myc could directly bind to the c-Myc binding site in promoter region of BCAT1 and up-regulate its expression. The mRNA and protein of c-Myc and BCAT1 were co-expressed in 53.6% (15/28) and 59.1% (13/22) of NPC tissues, respectively, and BCAT1 mRNA expression was also down-regulated in c-Myc knockdown cell lines. In addition, BCAT1 knockdown cells demonstrated reduced proliferation and decreased cell migration and invasion abilities.

Conclusions

Our study indicates that gene amplification and c-Myc up-regulation are responsible for BCAT1 overexpression in primary NPC, and overexpression of BCAT1 induces cell proliferation, migration and invasion. The results suggest that BCAT1 may be a novel molecular target for the diagnosis and treatment of NPC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yao KT: The application and prospect of nasopharyngeal carcinoma etiology. China Cancer. 1997, 6 (7): 3-4. Yao KT: The application and prospect of nasopharyngeal carcinoma etiology. China Cancer. 1997, 6 (7): 3-4.
2.
go back to reference Yung WC, Sham JS, Choy DT, Ng MH: ras mutations are uncommon in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol. 1995, 31B: 399-400.CrossRefPubMed Yung WC, Sham JS, Choy DT, Ng MH: ras mutations are uncommon in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol. 1995, 31B: 399-400.CrossRefPubMed
3.
go back to reference Lin HS, Berry GJ, Sun Z, Fee WE: Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol. 2006, 4: 62- 10.1186/1477-7819-4-62PubMedCentralCrossRefPubMed Lin HS, Berry GJ, Sun Z, Fee WE: Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol. 2006, 4: 62- 10.1186/1477-7819-4-62PubMedCentralCrossRefPubMed
4.
go back to reference Wu HC, Lu TY, Lee JJ, Hwang JK, Lin YJ, Wang CK, Lin CT: MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. Lab Invest. 2004, 84: 1547-1556. 10.1038/labinvest.3700183CrossRefPubMed Wu HC, Lu TY, Lee JJ, Hwang JK, Lin YJ, Wang CK, Lin CT: MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. Lab Invest. 2004, 84: 1547-1556. 10.1038/labinvest.3700183CrossRefPubMed
5.
go back to reference Guo X, Lui WO, Qian CN, Chen JD, Gray SG, Rhodes D, Haab B, Stanbridge E, Wang H, Hong MH: Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. Int J Oncol. 2002, 21: 1197-1204.PubMed Guo X, Lui WO, Qian CN, Chen JD, Gray SG, Rhodes D, Haab B, Stanbridge E, Wang H, Hong MH: Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. Int J Oncol. 2002, 21: 1197-1204.PubMed
6.
go back to reference Leong JL, Loh KS, Putti TC, Goh BC, Tan LK: Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope. 2004, 114: 153-157. 10.1097/00005537-200401000-00029CrossRefPubMed Leong JL, Loh KS, Putti TC, Goh BC, Tan LK: Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope. 2004, 114: 153-157. 10.1097/00005537-200401000-00029CrossRefPubMed
7.
go back to reference Porter MJ, Field JK, Lee JC, Leung SF, Lo D, Van Hasselt CA: Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res. 1994, 14: 1357-1360.PubMed Porter MJ, Field JK, Lee JC, Leung SF, Lo D, Van Hasselt CA: Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res. 1994, 14: 1357-1360.PubMed
8.
go back to reference Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Satake K, Koshika S, Nakatani Y, Hara M, Kato Y, Nagashima Y: Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev. 2001, 25: 414-419.PubMed Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Satake K, Koshika S, Nakatani Y, Hara M, Kato Y, Nagashima Y: Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev. 2001, 25: 414-419.PubMed
9.
go back to reference Zhou L, Jiang W, Ren C, Yin Z, Feng X, Liu W, Tao Q, Yao K: Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia. 2005, 7: 809-815. 10.1593/neo.05217PubMedCentralCrossRefPubMed Zhou L, Jiang W, Ren C, Yin Z, Feng X, Liu W, Tao Q, Yao K: Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia. 2005, 7: 809-815. 10.1593/neo.05217PubMedCentralCrossRefPubMed
10.
go back to reference Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H, Yao KT: Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin (Shanghai). 2006, 38: 349-355. 10.1111/j.1745-7270.2006.00164.x.CrossRef Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H, Yao KT: Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin (Shanghai). 2006, 38: 349-355. 10.1111/j.1745-7270.2006.00164.x.CrossRef
11.
go back to reference Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M, Yao KT, Ren CP: Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol Res. 2006, 16: 261-272.PubMed Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M, Yao KT, Ren CP: Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol Res. 2006, 16: 261-272.PubMed
12.
go back to reference Zhang H, Feng X, Liu W, Jiang X, Shan W, Huang C, Yi H, Zhu B, Zhou W, Wang L: Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines. J Cell Biochem. 2011, 112: 1832-1843. 10.1002/jcb.23101CrossRefPubMed Zhang H, Feng X, Liu W, Jiang X, Shan W, Huang C, Yi H, Zhu B, Zhou W, Wang L: Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines. J Cell Biochem. 2011, 112: 1832-1843. 10.1002/jcb.23101CrossRefPubMed
13.
go back to reference Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, Chan FL, Daigo Y, Nakamura Y, Huang DP, Lo KW: Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer. 2007, 46: 171-180. 10.1002/gcc.20398CrossRefPubMed Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, Chan FL, Daigo Y, Nakamura Y, Huang DP, Lo KW: Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer. 2007, 46: 171-180. 10.1002/gcc.20398CrossRefPubMed
14.
go back to reference Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML: Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer. 2004, 112: 628-635. 10.1002/ijc.20454CrossRefPubMed Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML: Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer. 2004, 112: 628-635. 10.1002/ijc.20454CrossRefPubMed
15.
go back to reference Huang Z, Desper R, Schaffer AA, Yin Z, Li X, Yao K: Construction of tree models for pathogenesis of nasopharyngeal carcinoma. Genes Chromosomes Cancer. 2004, 40: 307-315. 10.1002/gcc.20036CrossRefPubMed Huang Z, Desper R, Schaffer AA, Yin Z, Li X, Yao K: Construction of tree models for pathogenesis of nasopharyngeal carcinoma. Genes Chromosomes Cancer. 2004, 40: 307-315. 10.1002/gcc.20036CrossRefPubMed
16.
go back to reference Zhou W, Feng X, Li H, Wang L, Zhu B, Zhang H, Yao K, Ren C: Functional evidence for a nasopharyngeal carcinoma-related gene BCAT1 located at 12p12. Oncol Res. 2007, 16: 405-413.PubMed Zhou W, Feng X, Li H, Wang L, Zhu B, Zhang H, Yao K, Ren C: Functional evidence for a nasopharyngeal carcinoma-related gene BCAT1 located at 12p12. Oncol Res. 2007, 16: 405-413.PubMed
17.
go back to reference Ben-Yosef T, Yanuka O, Halle D, Benvenisty N: Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene. 1998, 17: 165-171. 10.1038/sj.onc.1201939CrossRefPubMed Ben-Yosef T, Yanuka O, Halle D, Benvenisty N: Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene. 1998, 17: 165-171. 10.1038/sj.onc.1201939CrossRefPubMed
18.
go back to reference Pinkel D, Albertson DG: Array comparative genomic hybridization and its applications in cancer. Nat Genet. 2005, 37: S11-S17. 10.1038/ng1569CrossRefPubMed Pinkel D, Albertson DG: Array comparative genomic hybridization and its applications in cancer. Nat Genet. 2005, 37: S11-S17. 10.1038/ng1569CrossRefPubMed
19.
go back to reference Tao Q, Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 2007, 9: 1-24.CrossRefPubMed Tao Q, Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 2007, 9: 1-24.CrossRefPubMed
20.
go back to reference Bledsoe RK, Dawson PA, Hutson SM: Cloning of the rat and human mitochondrial branched chain aminotransferases (BCATm). Biochim Biophys Acta. 1997, 1339: 9-13. 10.1016/S0167-4838(97)00044-7CrossRefPubMed Bledsoe RK, Dawson PA, Hutson SM: Cloning of the rat and human mitochondrial branched chain aminotransferases (BCATm). Biochim Biophys Acta. 1997, 1339: 9-13. 10.1016/S0167-4838(97)00044-7CrossRefPubMed
21.
go back to reference Eden A, Simchen G, Benvenisty N: Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases. J Biol Chem. 1996, 271: 20242-20245. 10.1074/jbc.271.34.20242CrossRefPubMed Eden A, Simchen G, Benvenisty N: Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases. J Biol Chem. 1996, 271: 20242-20245. 10.1074/jbc.271.34.20242CrossRefPubMed
22.
go back to reference Schuldiner O, Eden A, Ben-Yosef T, Yanuka O, Simchen G, Benvenisty N: ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proc Natl Acad Sci USA. 1996, 93: 7143-7148. 10.1073/pnas.93.14.7143PubMedCentralCrossRefPubMed Schuldiner O, Eden A, Ben-Yosef T, Yanuka O, Simchen G, Benvenisty N: ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proc Natl Acad Sci USA. 1996, 93: 7143-7148. 10.1073/pnas.93.14.7143PubMedCentralCrossRefPubMed
23.
go back to reference Eden A, Benvenisty N: Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis. FEBS Lett. 1999, 457: 255-261. 10.1016/S0014-5793(99)01054-6CrossRefPubMed Eden A, Benvenisty N: Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis. FEBS Lett. 1999, 457: 255-261. 10.1016/S0014-5793(99)01054-6CrossRefPubMed
24.
go back to reference Rodriguez S, Jafer O, Goker H, Summersgill B, Zafarana G, Gillis AJ, van Gurp RJ, Oosterhuis JW, Lu YJ, Huddart R: Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene. 2003, 22: 1880-1891. 10.1038/sj.onc.1206302CrossRefPubMed Rodriguez S, Jafer O, Goker H, Summersgill B, Zafarana G, Gillis AJ, van Gurp RJ, Oosterhuis JW, Lu YJ, Huddart R: Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene. 2003, 22: 1880-1891. 10.1038/sj.onc.1206302CrossRefPubMed
25.
go back to reference Ben-Yosef T, Eden A, Benvenisty N: Characterization of murine BCAT genes: Bcat1, a c-Myc target, and its homolog, Bcat2. Mamm Genome. 1998, 9: 595-597. 10.1007/s003359900825CrossRefPubMed Ben-Yosef T, Eden A, Benvenisty N: Characterization of murine BCAT genes: Bcat1, a c-Myc target, and its homolog, Bcat2. Mamm Genome. 1998, 9: 595-597. 10.1007/s003359900825CrossRefPubMed
26.
go back to reference Weggen S, Preuss U, Pietsch T, Hilger N, Klawitz I, Scheidtmann KH, Wiestler OD, Bayer TA: Identification of amplified genes from SV40 large T antigen-induced rat PNET cell lines by subtractive cDNA analysis and radiation hybrid mapping. Oncogene. 2001, 20: 2023-2031. 10.1038/sj.onc.1204287CrossRefPubMed Weggen S, Preuss U, Pietsch T, Hilger N, Klawitz I, Scheidtmann KH, Wiestler OD, Bayer TA: Identification of amplified genes from SV40 large T antigen-induced rat PNET cell lines by subtractive cDNA analysis and radiation hybrid mapping. Oncogene. 2001, 20: 2023-2031. 10.1038/sj.onc.1204287CrossRefPubMed
27.
go back to reference Rodenhuis S, Slebos RJ: The ras oncogenes in human lung cancer. Am Rev Respir Dis. 1990, 142: S27-30. 10.1164/ajrccm/142.6_Pt_2.S27CrossRefPubMed Rodenhuis S, Slebos RJ: The ras oncogenes in human lung cancer. Am Rev Respir Dis. 1990, 142: S27-30. 10.1164/ajrccm/142.6_Pt_2.S27CrossRefPubMed
28.
go back to reference Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS: Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997, 19: 93-101. 10.1097/00043426-199703000-00001CrossRefPubMed Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS: Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997, 19: 93-101. 10.1097/00043426-199703000-00001CrossRefPubMed
29.
go back to reference Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A: HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997, 15: 2894-2904.PubMed Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A: HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997, 15: 2894-2904.PubMed
30.
go back to reference Sun D, Zhang Z, Van do N, Huang G, Ernberg I, Hu L: Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol. 2007, 43: 82-87. 10.1016/j.oraloncology.2006.01.007CrossRefPubMed Sun D, Zhang Z, Van do N, Huang G, Ernberg I, Hu L: Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol. 2007, 43: 82-87. 10.1016/j.oraloncology.2006.01.007CrossRefPubMed
31.
go back to reference Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, Johnson PJ, Huang DP: Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol. 2000, 31: 169-178. 10.1016/S0046-8177(00)80216-6CrossRefPubMed Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, Johnson PJ, Huang DP: Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol. 2000, 31: 169-178. 10.1016/S0046-8177(00)80216-6CrossRefPubMed
32.
go back to reference Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ: Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 2010, 6: e1000940- 10.1371/journal.ppat.1000940PubMedCentralCrossRefPubMed Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ: Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 2010, 6: e1000940- 10.1371/journal.ppat.1000940PubMedCentralCrossRefPubMed
33.
go back to reference Huang GW, Mo WN, Kuang GQ, Nong HT, Wei MY, Sunagawa M, Kosugi T: Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma. Laryngoscope. 2001, 111: 1465-1471. 10.1097/00005537-200108000-00025CrossRefPubMed Huang GW, Mo WN, Kuang GQ, Nong HT, Wei MY, Sunagawa M, Kosugi T: Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma. Laryngoscope. 2001, 111: 1465-1471. 10.1097/00005537-200108000-00025CrossRefPubMed
34.
go back to reference Lung HL, Cheung AK, Xie D, Cheng Y, Kwong FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI: TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res. 2006, 66: 9385- 10.1158/0008-5472.CAN-06-0590CrossRefPubMed Lung HL, Cheung AK, Xie D, Cheng Y, Kwong FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI: TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res. 2006, 66: 9385- 10.1158/0008-5472.CAN-06-0590CrossRefPubMed
35.
go back to reference Peng SP, Li XL, Wang L, Ou-Yang J, Ma J, Wang LL, Liu HY, Zhou M, Tang YL, Li WS: The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology. 2006, 71: 273-281. 10.1159/000106073CrossRefPubMed Peng SP, Li XL, Wang L, Ou-Yang J, Ma J, Wang LL, Liu HY, Zhou M, Tang YL, Li WS: The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology. 2006, 71: 273-281. 10.1159/000106073CrossRefPubMed
36.
go back to reference Yoshikawa R, Yanagi H, Shen CS, Fujiwara Y, Noda M, Yagyu T, Gega M, Oshima T, Yamamura T, Okamura H: ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World J Gastroenterol. 2006, 12: 5884-5889.PubMedCentralPubMed Yoshikawa R, Yanagi H, Shen CS, Fujiwara Y, Noda M, Yagyu T, Gega M, Oshima T, Yamamura T, Okamura H: ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World J Gastroenterol. 2006, 12: 5884-5889.PubMedCentralPubMed
37.
go back to reference de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, Luider TM, den Boer ML, Pieters R: Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol. 2008, 10: 648-660. 10.1215/15228517-2008-032PubMedCentralCrossRefPubMed de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, Luider TM, den Boer ML, Pieters R: Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol. 2008, 10: 648-660. 10.1215/15228517-2008-032PubMedCentralCrossRefPubMed
38.
go back to reference Song LB, Yan J, Jian SW, Zhang L, Li MZ, Li D, Wang HM: [Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines]. Ai Zheng. 2002, 21: 158-162.PubMed Song LB, Yan J, Jian SW, Zhang L, Li MZ, Li D, Wang HM: [Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines]. Ai Zheng. 2002, 21: 158-162.PubMed
39.
go back to reference Wanggou S, Jiang X, Li Q, Zhang L, Liu D, Li G, Feng X, Liu W, Zhu B, Huang W: HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma. J Neurooncol. 2012, 106: 251-259. 10.1007/s11060-011-0673-7CrossRefPubMed Wanggou S, Jiang X, Li Q, Zhang L, Liu D, Li G, Feng X, Liu W, Zhu B, Huang W: HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma. J Neurooncol. 2012, 106: 251-259. 10.1007/s11060-011-0673-7CrossRefPubMed
Metadata
Title
Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma
Authors
Wen Zhou
Xiangling Feng
Caiping Ren
Xingjun Jiang
Weidong Liu
Wei Huang
Zhihong Liu
Zan Li
Liang Zeng
Lei Wang
Bin Zhu
Jia Shi
Jie Liu
Chang Zhang
Yanyu Liu
Kaitai Yao
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2013
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-12-53

Other articles of this Issue 1/2013

Molecular Cancer 1/2013 Go to the issue

Reviewer acknowledgement

Thanking our peer reviewers

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine